CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 180 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,609,206 | -57.2% | 165,317 | -54.6% | 0.03% | -58.6% |
| Q1 2023 | $13,106,543 | -43.5% | 364,273 | -30.1% | 0.07% | -44.4% |
| Q4 2022 | $23,215,265 | +86.2% | 520,872 | +17.4% | 0.13% | +100.0% |
| Q3 2022 | $12,471,000 | +90.0% | 443,642 | +82.3% | 0.06% | +103.2% |
| Q2 2022 | $6,562,000 | +23.6% | 243,383 | +56.2% | 0.03% | +82.4% |
| Q1 2022 | $5,307,000 | -72.6% | 155,804 | -69.0% | 0.02% | -65.3% |
| Q4 2021 | $19,402,000 | -31.7% | 502,125 | -4.5% | 0.05% | -27.9% |
| Q3 2021 | $28,392,000 | – | 525,867 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
| Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
| TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
| 5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
| COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
| ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
| Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
| RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
| Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
| Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |